Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC). | J Immunother Cancer | 2022 | 35277461 | PubTator, text mining | PubMed |
| Immunotherapy in Advanced Prostate Cancer-Light at the End of the Tunnel? | Int J Mol Sci | 2022 | 35269712 | PubTator, text mining | PubMed |
| Epigenetics of Dendritic Cells in Tumor Immunology. | Cancers (Basel) | 2022 | 35267487 | PubTator, text mining | PubMed |
| Utilizing Bioinformatics Technology to Explore the Potential Mechanism of Danggui Buxue Decoction against NSCLC. | Dis Markers | 2022 | 35256890 | PubTator, text mining | PubMed |
| Immune mechanisms behind prostate cancer in men of African ancestry: A review. | Prostate | 2022 | 35254710 | PubTator, text mining | PubMed |
| Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens? | Int J Mol Sci | 2022 | 35216137 | PubTator, text mining | PubMed |
| Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized Therapy. | Cancers (Basel) | 2022 | 35205640 | PubTator, text mining | PubMed |
| Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number. | Biol Direct | 2022 | 35197090 | PubTator, text mining | PubMed |
| Peptides for Vaccine Development. | ACS Appl Bio Mater | 2022 | 35195008 | PubTator, text mining | PubMed |
| Innovative developments and emerging technologies in RNA therapeutics. | RNA Biol | 2022 | 35188077 | PubTator, text mining | PubMed |
| Cancer Immunotherapies: What the Perioperative Physician Needs to Know. | Curr Oncol Rep | 2022 | 35141856 | PubTator, text mining | PubMed |
| Electroacupuncture relieves neuropathic pain by inhibiting degradation of the ecto-nucleotidase PAP in the dorsal root ganglions of CCI mice. | Eur J Pain | 2022 | 35138669 | PubTator, text mining | PubMed |
| Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy. | J Immunother Cancer | 2022 | 35135866 | PubTator, text mining | PubMed |
| GM-CSF elicits antibodies to tumor-associated proteins when used as a prostate cancer vaccine adjuvant. | Cancer Immunol Immunother | 2022 | 35133464 | PubTator, text mining | PubMed |
| Targets of immunotherapy for hepatocellular carcinoma: An update. | World J Hepatol | 2022 | 35126844 | PubTator, text mining | PubMed |
| Optimization of small extracellular vesicle isolation from expressed prostatic secretions in urine for in-depth proteomic analysis. | J Extracell Vesicles | 2022 | 35119778 | PubTator, text mining | PubMed |
| RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures. | Cancer Cell Int | 2022 | 35109825 | PubTator, text mining | PubMed |
| Declining serum bone turnover markers are associated with the short-term positive change of lumbar spine bone mineral density in postmenopausal women. | Menopause | 2022 | 35102102 | PubTator, text mining | PubMed |
| Mining the Biomarkers and Associated-Drugs for Esophageal Squamous Cell Carcinoma by Bioinformatic Methods. | Tohoku J Exp Med | 2022 | 35067492 | PubTator, text mining | PubMed |
| Effects of high serum uric acid levels on oxidative stress levels and semen parameters in male infertile patients. | Medicine (Baltimore) | 2022 | 35060497 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=20